The studies by Baolai Zhang et al., [33] and Lakshmi Prabhu et al., [34] evidenced that PRMT5 was overexpressed in colorectal cancer cells which promoted cancer progression, while its expression in patient-derived primary tumors correlated with increased cell growth and decreased overall patient survival. This evidence concerns the gene PRMT5 and colorectal cancer.